PolyI:C, a synthetic double-stranded RNA molecules which targets the MDA-5/RIG-I pathway and TLR3 has been studied for many years as a standalone cancer therapy or vaccine adjuvant23,41. This evidence concerns the gene TLR3 and cancer.